Stay updated on GR-MD-02 for NASH Cirrhosis: Safety & Efficacy Clinical Trial

Sign up to get notified when there's something new on the GR-MD-02 for NASH Cirrhosis: Safety & Efficacy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the GR-MD-02 for NASH Cirrhosis: Safety & Efficacy Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    Expanded the Locations section to list each state individually (California, Colorado, Florida, Georgia, Illinois, Indiana, Louisiana, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, New York, North Carolina, Ohio, Pennsylvania, Rhode Island, South Carolina, Tennessee, Texas, Utah, Virginia, Washington) and added Revision: v3.3.3, replacing the previous aggregated state listings (v3.3.2).
    Difference
    2%
    Check dated 2025-12-23T20:14:56.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    37 days ago
    Change Detected
    Summary
    The changes modify publication metadata by adding statements that publications are provided voluntarily and automatically filled from PubMed, and by updating the revision label to v3.3.2, while removing the prior wording about PubMed-derived publications and the v3.2.0 revision. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-25T10:23:26.000Z thumbnail image
  6. Check
    44 days ago
    Change Detected
    Summary
    A government funding/operating status notice was removed from the page. The study details, including the NCT number, title, endpoints, and listed locations, remain unchanged.
    Difference
    0.3%
    Check dated 2025-11-18T06:48:03.000Z thumbnail image
  7. Check
    58 days ago
    Change Detected
    Summary
    - Minor user interface and formatting updates with no changes to study details, eligibility criteria, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.3%
    Check dated 2025-11-03T20:40:13.000Z thumbnail image
  8. Check
    87 days ago
    Change Detected
    Summary
    Introducing a major status notice about funding-related operation limitations and updating the version to v3.2.0. The page now communicates potential processing delays and directs users to official sources, marking a shift in reliability and availability information.
    Difference
    2%
    Check dated 2025-10-06T04:57:04.000Z thumbnail image
  9. Check
    94 days ago
    Change Detected
    Summary
    Added a new version tag (v3.1.0) and removed several drug-safety related topics (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs), indicating a content restructuring.
    Difference
    0.2%
    Check dated 2025-09-29T02:57:02.000Z thumbnail image

Stay in the know with updates to GR-MD-02 for NASH Cirrhosis: Safety & Efficacy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the GR-MD-02 for NASH Cirrhosis: Safety & Efficacy Clinical Trial page.